Evaluation of Hematological, Inflammatory and Coagulation Biomarkers as an Indicator of COVID-19 Severity

被引:0
|
作者
AYDIN, Nurten Nur [1 ]
AYDIN, Murat [1 ]
YILMAZ, Sibel I. B. A. [1 ]
机构
[1] Erzurum Reg Training & Res Hosp, Clin Infect Dis & Clin Microbiol, Erzurum, Turkiye
来源
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI | 2023年 / 28卷 / 02期
关键词
COVID-19; Biomarker; Lymphocyte-CRP ratio (LCR); Fibrinogen-albumin ratio (FAR); DISEASE SEVERITY; PARAMETERS; INFECTION; MARKERS;
D O I
10.5578/flora.20239918
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Introduction: The aim of this study is to investigate the relationship between the severity of coronavirus disease-19 (COVID-19) with hematological, biochemical and coagulation parameters. Materials and Methods: This study included 277 hospitalized patients who were diagnosed with COVID-19 by realtime polymerase chain reaction (PCR) analysis of nasopharyngeal swab sample between January and May 2021. According to the World Health Organization (WHO) COVID-19 severity classification, patients were divided into two groups as mild/moderate group (non-severe) and severe/critical group (severe). Demographic data of the patients and laboratory parameters at the time of hospitalization were evaluated retrospectively. Results: The neutrophil count was significantly higher in the severe group (p= 0.021), while the lymphocyte and thrombocyte counts were significantly lower (p< 0.001, p= 0.031, respectively). Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, mean platelet volume-lymphocyte ratio were significantly higher in the severe group (p< 0.001, p= 0.001, p< 0.001, respectively), while lymphocyte-monocyte ratio was lower (p= 0.005). C-reactive protein (CRP), ferritin, D-dimer, fibrinogen and prothrombin time were significantly higher in the severe group (p< 0.001, p< 0.001, p= 0.004, p< 0.001, p= 0.033, respectively), albumin levels were lower (p< 0.001). Blood urea nitrogen-albumin ratio, CRP-albumin ratio, fibrinogen-albumin ratio (FAR) were significantly higher and lymphocyte-CRP ratio (LCR) was lower in the severe group (p< 0.001 for each). The area under the curve (AUC) of the LCR value was 0.747 in ROC analyzes performed between both groups. When the LCR cut-off value was 0.14, 86.9% sensitivity and 52.9% specificity were detected. When the cut-off value of CRP was 13.2 mg/L, 0.724 AUC was detected with 82.0% sensitivity and 57.1% specificity. FAR showed 59.3% sensitivity and 72.2% specificity at a cut-off value of 12.17 (AUC= 0.696). Ferritin showed 72.7% sensitivity and 55.6% specificity at a cut-off value of 189 ng/mL (AUC= 0.691). A strong correlation was found between FAR and CRP in the correlation analysis (r= 0.724, p< 1000). In addition, a relationship was found between FAR and ferritin (r= 0.454, p< 1000). Conclusion: These laboratory parameters can be used as suitable biomarkers to determine the severity of COVID-19. These can help clinicians identify potentially serious cases at an early stage and enable early medical management.
引用
收藏
页码:188 / 197
页数:10
相关论文
共 50 条
  • [31] Inflammatory Response and Activation of Coagulation after COVID-19 Infection
    Teodoro, Anna Gloria Fonseca
    Rodrigues, Wellington Francisco
    Farnesi-de-Assuncao, Thais Soares
    Bernardes e Borges, Anna V.
    Obata, Malu Mateus Santos
    Neto, Jose Rodrigues do Carmo
    da Silva, Djalma A. Alves
    Andrade-Silva, Leonardo E.
    Desiderio, Chamberttan S.
    Costa-Madeira, Juliana C.
    Barbosa, Rafaela M.
    Cunha, Andrezza C. C. Hortolani
    Pereira, Loren Q.
    de Vito, Fernanda Bernadelli
    Tanaka, Sarah Cristina Sato Vaz
    Helmo, Fernanda R. R.
    Lemes, Marcela Rezende
    Barbosa, Lais M.
    Trevisan, Rafael O. . O.
    Mundim, Fabiano V. V.
    Oliveira-Scussel, Ana Carolina M.
    Resende Jr, Paulo Roberto
    Monteiro, Ivan B.
    Ferreira, Yulsef M.
    Machado, Guilherme H.
    Ferreira-Paim, Kennio
    Moraes-Souza, Helio
    de Oliveira, Carlo Jose Freire
    Rodrigues Junior, Virmondes
    da Silva, Marcos Vinicius
    VIRUSES-BASEL, 2023, 15 (04):
  • [32] Evaluation of urinary cysteinyl leukotrienes as biomarkers of severity and putative therapeutic targets in COVID-19 patients
    Marta Reina-Couto
    Mariana Roboredo-Madeira
    Patrícia Pereira-Terra
    Carolina Silva-Pereira
    Sandra Martins
    Luísa Teixeira-Santos
    Dora Pinho
    Andreia Dias
    Gonçalo Cordeiro
    Cláudia Camila Dias
    António Sarmento
    Margarida Tavares
    João T. Guimarães
    Roberto Roncon-Albuquerque
    José-Artur Paiva
    António Albino-Teixeira
    Teresa Sousa
    Inflammation Research, 2023, 72 : 475 - 491
  • [33] Hematological alterations associated with long COVID-19
    Lechuga, Guilherme C.
    Morel, Carlos M.
    De-Simone, Salvatore Giovanni
    FRONTIERS IN PHYSIOLOGY, 2023, 14
  • [34] Hematological manifestations of COVID-19
    Mina, Alain
    Van Besien, Koen
    Platanias, Leonidas C.
    LEUKEMIA & LYMPHOMA, 2020, 61 (12) : 2790 - 2798
  • [35] The Role of Sequentially Monitored Laboratory Values and Inflammatory Biomarkers in Assessing the Severity of COVID-19
    Baran, Burcu
    Yetkin, Nur A.
    Tutar, Nuri
    Ture, Zeynep
    Oymak, Fatma S.
    Gulmez, Inci
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [36] Hematological and Inflammatory Parameters to Predict the Prognosis in COVID-19
    Hakan Keski
    Indian Journal of Hematology and Blood Transfusion, 2021, 37 : 534 - 542
  • [37] Cytokine Signature Associated With Disease Severity in COVID-19
    Guo, Jing
    Wang, Shuting
    Xia, He
    Shi, Ding
    Chen, Yu
    Zheng, Shufa
    Chen, Yanfei
    Gao, Hainv
    Guo, Feifei
    Ji, Zhongkang
    Huang, Chenjie
    Luo, Rui
    Zhang, Yan
    Zuo, Jian
    Chen, Yunbo
    Xu, Yan
    Xia, Jiafeng
    Zhu, Chunxia
    Xu, Xiaowei
    Qiu, Yunqing
    Sheng, Jifang
    Xu, Kaijin
    Li, Lanjuan
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [38] Hematological and Inflammatory Parameters to Predict the Prognosis in COVID-19
    Keski, Hakan
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2021, 37 (04) : 534 - 542
  • [39] Inflammatory and Hypercoagulable Biomarkers and Clinical Outcomes in COVID-19 Patients
    Kitakata, Hiroki
    Kohsaka, Shun
    Kuroda, Shunsuke
    Nomura, Akihiro
    Kitai, Takeshi
    Yonetsu, Taishi
    Torii, Sho
    Matsue, Yuya
    Matsumoto, Shingo
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (14)
  • [40] Routine Hematological Parameters May Be Predictors of COVID-19 Severity
    Szklanna, Paulina B.
    Altaie, Haidar
    Comer, Shane P.
    Cullivan, Sarah
    Kelliher, Sarah
    Weiss, Luisa
    Curran, John
    Dowling, Emmet
    O'Reilly, Katherine M. A.
    Cotter, Aoife G.
    Marsh, Brian
    Gaine, Sean
    Power, Nick
    Lennon, Aine
    McCullagh, Brian
    Ni Ainle, Fionnuala
    Kevane, Barry
    Maguire, Patricia B.
    FRONTIERS IN MEDICINE, 2021, 8